Allex

RSS

desloratadine

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Allex has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 31/12/2009

Authorisation details

Product details
Name
Allex
Agency product number
EMEA/H/C/000312
Active substance
desloratadine
International non-proprietary name (INN) or common name
desloratadine
Therapeutic area (MeSH)
  • Rhinitis, Allergic, Perennial
  • Urticaria
  • Rhinitis, Allergic, Seasonal
Anatomical therapeutic chemical (ATC) code
R06AX27
Publication details
Marketing-authorisation holder
Schering-Plough Europe
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
15/01/2001
Contact address
SP Europe
Rue de Stalle, 73
B-1180 Bruxelles
Belgium

Product information

31/12/2009 Allex - EMEA/H/C/000312 -

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Antihistamines for systemic use

Therapeutic indication

Aerius is indicated for the relief of symptoms associated with:
- allergic rhinitis (see section 5.1)
- urticaria (see section 5.1)

How useful was this page?

Add your rating